Ingevity Corp (NGVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,100 | 68,000 | 95,900 | 76,700 | 275,400 |
| Receivables | 127,200 | 131,700 | 182,000 | 224,800 | 161,700 |
| Inventories | 186,000 | 195,900 | 308,800 | 335,000 | 241,200 |
| Other current assets | 15,900 | 46,500 | 0 | 0 | 0 |
| TOTAL | $454,200 | $493,200 | $658,600 | $683,300 | $724,900 |
| Non-Current Assets | |||||
| PPE Net | 608,100 | 642,900 | 762,200 | 798,600 | 719,700 |
| Investments And Advances | 167,500 | 168,900 | 178,300 | 187,800 | 111,400 |
| Intangibles | 180,400 | 454,000 | 863,600 | 923,300 | 779,600 |
| Other Non-Current Assets | 240,900 | 263,600 | 160,600 | 143,500 | 133,400 |
| TOTAL | $1,196,900 | $1,529,400 | $1,964,700 | $2,053,200 | $1,744,100 |
| Total Assets | $1,651,100 | $2,022,600 | $2,623,300 | $2,736,500 | $2,469,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 92,000 | 94,500 | 158,400 | 174,800 | 125,800 |
| Accrued Expenses | 182,600 | 85,400 | 92,200 | 107,700 | 99,900 |
| TOTAL | $341,300 | $264,100 | $362,900 | $303,500 | $268,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,161,400 | 1,339,700 | 1,382,800 | 1,472,500 | 1,250,000 |
| Other Non-Current Liabilities | 63,600 | 167,400 | 175,300 | 155,700 | 43,600 |
| TOTAL | $1,280,100 | $1,563,300 | $1,629,000 | $1,734,700 | $1,526,300 |
| Total Liabilities | $1,621,400 | $1,827,400 | $1,991,900 | $2,038,200 | $1,795,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,292 | 36,351 | 36,236 | 37,151 | 39,000 |
| Common Shares | 400 | 400 | 400 | 400 | 400 |
| Retained earnings | 404,900 | 572,000 | 1,002,300 | 1,007,700 | 796,100 |
| Other shareholders' equity | 700 | -41,000 | -26,200 | -46,800 | 13,000 |
| TOTAL | $29,700 | $195,200 | $631,400 | $698,300 | $673,800 |
| Total Liabilities And Equity | $1,651,100 | $2,022,600 | $2,623,300 | $2,736,500 | $2,469,000 |